Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Raynaud's Disease”

85 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 85 results

Not applicableStudy completedNCT02506062
What this trial is testing

A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)

Who this might be right for
Raynaud DiseaseRaynaud's Phenomenon
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 21
Not applicableUnknownNCT01378845
What this trial is testing

Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands

Who this might be right for
Raynaud's PhenomenonSkin Necrosis
Christoph Hehrlein 30
Not applicableLooking for participantsNCT06989216
What this trial is testing

Multi-modal Quantitative Imaging of the Skin

Who this might be right for
Skin CancerSkin DiseasesAtopic Dermatitis+4 more
HJN Sverige AB/Neko Health 8,000
Large-scale testing (Phase 3)Study completedNCT01347008
What this trial is testing

Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicScleroderma, DiffuseScleroderma, Limited+1 more
Federal University of São Paulo 41
Large-scale testing (Phase 3)UnknownNCT00577304
What this trial is testing

A Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon

Who this might be right for
Raynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Other Autoimmune Disease
MediQuest Therapeutics 200
Testing effectiveness (Phase 2)UnknownNCT02551042
What this trial is testing

CSL Behring Sclero XIII

Who this might be right for
Systemic Sclerosis
University College, London 26
Early research (Phase 1)Study completedNCT00700518
What this trial is testing

Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
Procris Pharmaceuticals 10
Not applicableLooking for participantsNCT06675344
What this trial is testing

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

Who this might be right for
Systemic Sclerosis (SSc)
Robyn T. Domsic, MD, MPH 160
Large-scale testing (Phase 3)Ended earlyNCT02374320
What this trial is testing

Exparel as a Nerve Block for Severe Hand Pain

Who this might be right for
CREST SyndromePeripheral Vascular DiseaseRaynaud Disease+1 more
Jose Soberon, MD 13
Post-approval studies (Phase 4)Study completedNCT00048776
What this trial is testing

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
Otsuka America Pharmaceutical 75
Very early researchWithdrawnNCT04656704
What this trial is testing

Hyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin Disease

Who this might be right for
MicrostomiaSclerodermaCREST Syndrome+2 more
Brigham and Women's Hospital
Testing effectiveness (Phase 2)Study completedNCT02688270
What this trial is testing

Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon Secondary to Connective Tissue Disease
Covis Pharma S.à.r.l. 65
Large-scale testing (Phase 3)Not Yet RecruitingNCT05698979
What this trial is testing

Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease

Who this might be right for
Buerger DiseaseRaynaud Syndrome
University Hospital, Toulouse 8
Testing effectiveness (Phase 2)Study completedNCT02260557
What this trial is testing

Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Actelion 74
Early research (Phase 1)Study completedNCT00841594
What this trial is testing

MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison

Who this might be right for
Raynaud's Phenomenon
MediQuest Therapeutics 12
Large-scale testing (Phase 3)Study completedNCT00419419
What this trial is testing

Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon

Who this might be right for
Raynaud's DiseaseSclerodermaAutoimmune Diseases
MediQuest Therapeutics 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07759557
What this trial is testing

Efficacy of A Non-Invasive Botulinum Toxin Microneedle Pad for the Treatment of Secondary Raynaud's Phenomenon

Who this might be right for
Systemic Sclerosis (SSc)Raynaud Disease Secondary to Scleroderma
Khon Kaen University 72
Very early researchStudy completedNCT03027674
What this trial is testing

Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud

Who this might be right for
Raynaud Phenomenon Due to TraumaRaynaud DiseaseSystem; Sclerosis+3 more
Pontificia Universidad Catolica de Chile 10
Large-scale testing (Phase 3)Study completedNCT02165111
What this trial is testing

Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome

Who this might be right for
SclerodermaRaynaud's Syndrome
Johns Hopkins University 40
Testing effectiveness (Phase 2)Study completedNCT04744207
What this trial is testing

Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Gesynta Pharma AB 94
Next Page